EphA2 Protein, Human (HEK293, His)
Based on 1 publication(s) in Google Scholar
EphA2 protein is a receptor tyrosine kinase that participates in bidirectional signaling with various ephrin A ligands, affecting cell migration, adhesion, proliferation and differentiation. It regulates cell adhesion and differentiation by interacting with DSG1 and inhibiting the ERK1/ERK2 signaling pathway. EphA2 Protein, Human (HEK293, His) is the recombinant human-derived EphA2 protein, expressed by HEK293 , with C-His labeled tag.
- Species: Human
- Source: HEK293
-
Storage:Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Technical Parameters
-
Product Properties
- Documentation
- Help & FAQs
Biological Activity
Description
EphA2 protein is a receptor tyrosine kinase that participates in bidirectional signaling with various ephrin A ligands, affecting cell migration, adhesion, proliferation and differentiation. It regulates cell adhesion and differentiation by interacting with DSG1 and inhibiting the ERK1/ERK2 signaling pathway. EphA2 Protein, Human (HEK293, His) is the recombinant human-derived EphA2 protein, expressed by HEK293 , with C-His labeled tag.
Background
EphA2 protein is a receptor tyrosine kinase that interacts with various membrane-bound ephrin-A family ligands on neighboring cells, leading to bidirectional signaling. This receptor is involved in regulating cell migration, adhesion, proliferation, and differentiation through forward and reverse signaling pathways. It plays a role in cell adhesion and differentiation by interacting with DSG1/desmoglein-1 and inhibiting the ERK1/ERK2 signaling pathway. Additionally, EphA2 protein may be involved in UV radiation-induced apoptosis and stimulate chemotactic cell migration independently of ligand binding. During development, it contributes to pattern formation and the development of fetal tissues, including angiogenesis, hindbrain development, and mammary gland morphogenesis. EphA2 protein also interacts with Ephrin-A5/EFNA5 to regulate lens fiber cells' shape and interactions, crucial for maintaining lens transparency. Moreover, it plays a role in bone remodeling by regulating osteoclastogenesis and osteoblastogenesis through its interaction with Ephrin-A2/EFNA2. Notably, EphA2 protein acts as a receptor for hepatitis C virus (HCV) in hepatocytes, facilitating viral cell entry by promoting the formation of CD81-CLDN1 receptor complexes and enhancing membrane fusion with HCV envelope glycoproteins.
Verified Bioactivity
1.This product does not contain protein kinase domain.
2.Measured by its binding ability in a functional ELISA. Immobilized rhEphA2 at 2 µg/mL (100 µL/well) can bind rmEphrin-A1. The ED50 for this effect is 4.594-4.847 ng/mL.
3.Measured in a cell proliferation assay using PC-3 cells. The ED50 for this effect is 0.8703 ng/mL, corresponding to a specific activity is 1.15×106 units/mg.
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Biochem Biophys Res Commun
Engineered MAP30ER: A plant toxin-derived platform for EGFR-Targeted delivery of protein and chemotherapeutic payloads. [Abstract]2025 Aug 30:776:152184. PMID: 40517671
Technical Parameters
-
Species Human
-
Source HEK293
-
Tag C-His
-
Accession
P29317/NP_004422.2 (A24-N534)
-
Molecular Construction
-
N-term
-
EphA2 (A24-N534)
Accession # P29317 -
His
-
C-term
-
-
Protein Length
Extracellular Domain
-
Synonyms
EPHA2; Protein Tyrosine Kinase; Prev. ECK; CTRCT6; Tyrosine-Protein Kinase Receptor ECK; EphA2; Ephrin Type-A Receptor 2; ARCC2; Epithelial Cell Receptor Protein Tyrosine Kinase; CTPP1; Receptor Protein-Tyrosine Kinase; CTPA; EPH Receptor A2; Epithelial C
-
AA Sequence
AQGKEVVLLDFAAAGGELGWLTHPYGKGWDLMQNIMNDMPIYMYSVCNVMSGDQDNWLRTNWVYRGEAERIFIELKFTVRDCNSFPGGASSCKETFNLYYAESDLDYGTNFQKRLFTKIDTIAPDEITVSSDFEARHVKLNVEERSVGPLTRKGFYLAFQDIGACVALLSVRVYYKKCPELLQGLAHFPETIAGSDAPSLATVAGTCVDHAVVPPGGEEPRMHCAVDGEWLVPIGQCLCQAGYEKVEDACQACSPGFFKFEASESPCLECPEHTLPSPEGATSCECEEGFFRAPQDPASMPCTRPPSAPHYLTAVGMGAKVELRWTPPQDSGGREDIVYSVTCEQCWPESGECGPCEASVRYSEPPHGLTRTSVTVSDLEPHMNYTFTVEARNGVSGLVTSRSFRTASVSINQTEPPKVRLEGRSTTSLSVSWSIPPPQQSRVWKYEVTYRKKGDSNSYNVRRTEGFSVTLDDLAPDTTYLVQVQALTQEGQGAGSKVHEFQTLSPEGSGN
-
Molecular Weight
Approximately 60-75 kDa, based on SDS-PAGE under reducing conditions, due to the glycosylation.
-
Glycosylation
Yes
-
Purity
≥ 95%, as determined by reducing SDS-PAGE.
Product Properties
Lyophilized powder.
1.Lyophilized from a 0.22 μm filtered solution of PBS, 5% trehalose, pH 7.4.
2.Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4.
Please refer to the lot-specific COA for specific buffer information.
<1 EU/μg, determined by LAL method.
It is not recommended to reconstitute to a concentration less than 100 μg/mL in ddH2O.
Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.
Room temperature in continental US; may vary elsewhere.
Documentation
-
Data Sheet (239 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Powered by Bioz
